Literature DB >> 31240706

Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations.

Sabine Pellett1, William H Tepp1, Eric A Johnson1.   

Abstract

Human-induced pluripotent stem cell (hiPSC)-derived neurons can be exquisitely sensitive to botulinum neurotoxins (BoNTs), exceeding sensitivity of the traditionally used mouse bioassay. In this report, four defined hiPSC-derived neuronal populations including primarily GABAergic, glutamatergic, dopaminergic, and motor neurons were examined for BoNT/A, B, C, D, E, and F sensitivity. The data indicate that sensitivity varies markedly for the BoNTs tested. Motor neurons are significantly more sensitive than other neuron types for all BoNTs except BoNT/D. Examination of SNARE protein levels and BoNT-specific cell surface protein receptors reveals few differences between the cell types except greater expression levels of the receptor protein SV2C and synapsin-IIa in motor neurons. This indicates that differential toxicity of BoNTs for motor neurons compared to other neuronal cell types involves multiple mechanisms.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  botulinum neurotoxin; cell-based assay; hiPSC; human cell lines; neurons

Mesh:

Substances:

Year:  2019        PMID: 31240706      PMCID: PMC7751886          DOI: 10.1002/1873-3468.13508

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  72 in total

1.  Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin.

Authors:  S Prabakaran; W Tepp; B R DasGupta
Journal:  Toxicon       Date:  2001-10       Impact factor: 3.033

Review 2.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

Review 3.  The synaptic split of SNAP-25: different roles in glutamatergic and GABAergic neurons?

Authors:  M Matteoli; D Pozzi; C Grumelli; S B Condliffe; C Frassoni; T Harkany; C Verderio
Journal:  Neuroscience       Date:  2008-03-20       Impact factor: 3.590

Review 4.  Using stem cell-derived neurons in drug screening for neurological diseases.

Authors:  Daniel Little; Robin Ketteler; Paul Gissen; Michael J Devine
Journal:  Neurobiol Aging       Date:  2019-02-20       Impact factor: 4.673

Review 5.  Progress in cell based assays for botulinum neurotoxin detection.

Authors:  Sabine Pellett
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

6.  Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons.

Authors:  Min Dong; Huisheng Liu; William H Tepp; Eric A Johnson; Roger Janz; Edwin R Chapman
Journal:  Mol Biol Cell       Date:  2008-09-24       Impact factor: 4.138

7.  Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro.

Authors:  Regina C M Whitemarsh; William H Tepp; Marite Bradshaw; Guangyun Lin; Christina L Pier; Jacob M Scherf; Eric A Johnson; Sabine Pellett
Journal:  Infect Immun       Date:  2013-08-05       Impact factor: 3.441

Review 8.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

9.  High resolution crystal structures of the receptor-binding domain of Clostridium botulinum neurotoxin serotypes A and FA.

Authors:  Jonathan R Davies; Gavin S Hackett; Sai Man Liu; K Ravi Acharya
Journal:  PeerJ       Date:  2018-03-21       Impact factor: 2.984

10.  Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.

Authors:  R Eleopra; V Tugnoli; O Rossetto; D De Grandis; C Montecucco
Journal:  Neurosci Lett       Date:  1998-11-13       Impact factor: 3.046

View more
  7 in total

1.  Transcription of the Envelope Protein by 1-L Protein-RNA Recognition Code Leads to Genes/Proteins That Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis.

Authors:  Jozef Nahalka
Journal:  Curr Issues Mol Biol       Date:  2022-02-06       Impact factor: 2.976

Review 2.  Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury.

Authors:  Michael Adler; Sabine Pellett; Shashi K Sharma; Frank J Lebeda; Zygmunt F Dembek; Mark A Mahan
Journal:  Microorganisms       Date:  2022-04-24

3.  Analysis of Motor Neurons Differentiated from Human Induced Pluripotent Stem Cells for the Use in Cell-Based Botulinum Neurotoxin Activity Assays.

Authors:  Maren Schenke; Brit-Maren Schjeide; Gerhard P Püschel; Bettina Seeger
Journal:  Toxins (Basel)       Date:  2020-04-25       Impact factor: 4.546

Review 4.  Critical Analysis of Neuronal Cell and the Mouse Bioassay for Detection of Botulinum Neurotoxins.

Authors:  Sabine Pellett; William H Tepp; Eric A Johnson
Journal:  Toxins (Basel)       Date:  2019-12-07       Impact factor: 4.546

Review 5.  Tables of Toxicity of Botulinum and Tetanus Neurotoxins.

Authors:  Ornella Rossetto; Cesare Montecucco
Journal:  Toxins (Basel)       Date:  2019-11-22       Impact factor: 4.546

6.  Human-Relevant Sensitivity of iPSC-Derived Human Motor Neurons to BoNT/A1 and B1.

Authors:  Maren Schenke; Hélène-Christine Prause; Wiebke Bergforth; Adina Przykopanski; Andreas Rummel; Frank Klawonn; Bettina Seeger
Journal:  Toxins (Basel)       Date:  2021-08-22       Impact factor: 4.546

7.  Optogenetically controlled human functional motor endplate for testing botulinum neurotoxins.

Authors:  Juliette Duchesne de Lamotte; Jérôme Polentes; Florine Roussange; Léa Lesueur; Pauline Feurgard; Anselme Perrier; Camille Nicoleau; Cécile Martinat
Journal:  Stem Cell Res Ther       Date:  2021-12-05       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.